The purpose of this study is to determine the bone mineral density in male and female patients with HIV infection according to age groups. This will enable a practical approach to screening for osteoporosis and the management and prevention of fragility fractures in people with HIV. In addition, all risk factors commonly associated with fragility fractures and osteoporosis are collected, as is HIV drug history. Hence, as secondary outcomes, the associations with reduced bone mineral density can be ascertained.
Study Type
OBSERVATIONAL
Enrollment
440
St Thomas, Hospital
London, United Kingdom
Bone mineral density at Hip
Bone mineral density as determined by DXA scanning
Time frame: The outcome is measured within 6 months (0-6 months) after entry to the study.
Bone mineral density at spine (L4)
As determined by DXA scan
Time frame: The outcome is measured within 6 months (0-6 months) after entry to the study.
Any lifetime fractures reported by subjects
Self-reported fractures of any type
Time frame: At any stage during persons life up to and including the last visit for the volunteer to the study.
Vitamin D levels
Plasma vitamin D
Time frame: The outcome is measured within 6 months (0-6 months) after entry to the study.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.